Personal profile

Education

  • PGY-I-III, Department of Internal Medicine St. Luke's Hospital,Temple University, Bethlehem, PA
  • Fellow, Department of Internal Medicine, Hematology and Bone Marrow Transplantation and Oncology Section, Yale University School of Medicine
  • Ph.D. in Pathology and Cell Biology, Thomas Jefferson University, Philadelphia
  • M.D., Taipei Medical College, Taipei, Taiwan

Experience

  • President and Chair Professor, Taipei Medical University
  • Affiliate Professor, California Institute of Technology, Pasadena, CA
  • Chair, The Chinese Oncology Society
  • Chair, ASCO International Affair Community
  • Chair, Molecular Pharmacology Department, City of Hope
  • Associate Director for Translational Research, City of Hope Comprehensive Cancer Center
  • Adjunct Professor, School of Pharmacy, University of Southern California
  • Adjunct Professor, Graduate Institute of Oncology, College of Medicine, National Taiwan University

Awards

  • Academician, International Academy of Engineering, Russia
  • Fellow, American Association for the Advancement of Science(AAAS)
  • Tang Prize Board Member
  • Board of Trustees, NHRI (Taiwan NIH), Taiwan
  • Kuong-Chi Scholar, Zhejiang University, Hangzhou, China
  • Steering Committee of Ming Hsieh Institute, USA
  • Who’s Who International and Professional Member (life member)
  • America’s Top Doctor (life member)
  • Hedvig Foundation Award
  • Cooper Portrait for Scientific Achievement Award in Cooper Auditorium, City of Hope
  • Distinguished Alumnus Award, Thomas Jefferson University, Philadelphia

Research Interests

  • Cancer Research
  • Translational Medicine

 

Fingerprint Fingerprint is based on mining the text of the persons scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 62 Similar Profiles
Neoplasms Medicine & Life Sciences
Ribonucleotide Reductases Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Proteins Medicine & Life Sciences
Genes Medicine & Life Sciences
Hepatocellular Carcinoma Medicine & Life Sciences
Biological Markers Medicine & Life Sciences
Cell Line Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2013 2016

Research Output 1994 2017

  • 7691 Citations
  • 44 h-Index
  • 261 Article
  • 4 Chapter
  • 1 Conference contribution

Does aspirin use reduce the risk for cancer?

Usman, I., Yang, H. C., Jian, W. S., Yen, Y. & Li, Y. C. Feb 1 2017 In : Journal of Investigative Medicine. 65, 2, p. 391-392 2 p.

Research output: Contribution to journalArticle

Aspirin
Neoplasms
Digestive System
International Classification of Diseases
Taiwan

Interactive role of diabetes mellitus and female sex in the risk of cholangiocarcinoma: A population-based nested case-control study

Huang, Y. J., Wu, A. T. H., Chiou, H. Y., Chuang, M. T., Meng, T. C., Chien, L. N. & Yen, Y. 2017 In : Oncotarget. 8, 4, p. 6642-6651 10 p.

Research output: Contribution to journalArticle

Cholangiocarcinoma
Diabetes Mellitus
Cholecystectomy
Taiwan
Confidence Intervals

Mechanism and clinical properties of stembios cell therapy: Induction of early osseointegration in novel dental implants

Weng, C. C., Ou, K. L., Wu, C. Y., Huang, Y. H., Wang, J., Yen, Y., Cheng, H. Y. & Lin, Y. H. 2017 In : International Journal of Oral and Maxillofacial Implants. 32, 1, p. e47-e54

Research output: Contribution to journalArticle

Cell- and Tissue-Based Therapy
Dental Implants
Bone and Bones
Osseointegration
Atomic Force Microscopy

A phase I pharmacodynamic study of GTI-2040, an antisense oligonucleotide against ribonuclotide reductase, in acute leukemias: a California Cancer Consortium study

Kirschbaum, M. H., Frankel, P., Synold, T. W., Xie, Z., Yen, Y., Popplewell, L., Chen, R., Aljitawi, O., Tuscano, J. M., Chan, K. K. & Newman, E. M. Feb 19 2016 In : Leukemia and Lymphoma. p. 1-8 8 p.

Research output: Contribution to journalArticle

Antisense Oligonucleotides
Appointments and Schedules
Oxidoreductases
Leukemia
Ribonucleotide Reductases

Autophagy induction causes a synthetic lethal sensitization to ribonucleotide reductase inhibition in breast cancer cells

Chen, Y. R., Tsou, B., Hu, S., Ma, H., Liu, X., Yen, Y. & Ann, D. K. 2016 In : Oncotarget. 7, 2, p. 1984-1999 16 p.

Research output: Contribution to journalArticle

Ribonucleotide Reductases
Autophagy
Breast Neoplasms
Deoxyribonucleotides
Tamoxifen

Press / Media

Researchers find way to detect nanoparticle effect

Yun Yen

4/9/16

1 item of media coverage

Press / Media

Nanoparticle-based cancer therapies shown to work in humans

Yun Yen

3/21/163/23/16

4 items of media coverage

Press / Media

Nanoparticle-Based Cancer Therapies Shown to Work in Humans

Yun Yen

3/21/16

1 item of media coverage

Press / Media